New capability provides sponsors and CROs
holistic view of sites' patient recruitment progress
COLUMBIA, Md., July 24,
2024 /PRNewswire/ -- Advarra, the market
leader in regulatory review solutions and clinical research
technology for sites and sponsors, today announced new
functionality to centralize all patient recruitment activities into
a single view. Advarra's novel recruitment oversight capabilities
in Longboat bring together patient recruitment planning,
pre-screening, referral sources, and workflow tools to provide
real-time visibility into recruitment progress. This new capability
addresses one of the research industry's primary roadblocks to
trial execution: managing the patient recruitment workflow for
sponsors, contract research organizations (CROs), and sites. Early
use shows that clinical trials utilizing Longboat are 27% more
likely to achieve recruitment goals.
Advarra accelerates enrollment with new
patient recruitment oversight capabilities for sites, sponsors, and
CROs.
Meeting patient enrollment targets is critical, often demanding
multiple recruitment sources. From trial matching tools to
data-guided products plus sites' internal systems, the number of
ways the research industry connects patients to clinical trials
continues to grow rapidly. In fact, Advarra's 2023 Study Activation
Survey reports that more than three quarters of sites are
offered patient referrals from a variety of sources in at least 25%
of their studies. And, when offered referrals, 40% say they work
with more than one recruitment resource on a single study. As a
result, there is no single source of information on the progress of
patient recruitment, while already strained sites are burdened
juggling various tools with no clear line-of-site on status.
Longboat's new patient recruitment oversight capability pulls
this disparate recruitment information into a comprehensive
dashboard, providing all stakeholders insight to the progress of
recruiting activities, reducing the site's burden and creating
trial efficiency.
"Successful patient recruitment is critical to running trials,
so sponsors and CROs must carefully oversee how recruitment efforts
are progressing, but it's difficult when there are so many
different sources of information," said Karen McIntyre,
Parexel's Vice President, Global Site Alliances. "Sites get
frustrated when they are interrupted by endless calls asking for
updates. With Longboat's patient recruitment functionality, every
stakeholder has real-time visibility and a holistic view of
progress without chasing information. In a few clicks, everyone is
updated. It eliminates a major barrier to speed."
Longboat also provides a site-specific recruitment planning tool
to align the strategy between sites and sponsors/CROs as well as an
Interactive Response Technology (IRT) integration to provide
visibility on the entire patient funnel, from initial patient
pre-screen and enrollment, to creating and sending 'thank you'
letters to all study participants at the conclusion of the trial.
The aggregation of this functionality into a single tool with
drill-down dashboards alerts study teams to recruitment issues
sooner so they can course-correct faster – significant, given that
patient recruitment is the single biggest cause of trial delays.
About 80% of trials fail to meet initial patient enrollment goals,
and these delays can result in lost revenue of as much as U.S.
$500,000 per day. In fact, on
average, 20% - 50% of trials will require rescue sites to cure
unmet enrollment targets, increasing costs and delaying
milestones.
"Patient recruitment remains one of the greatest challenges to
study timelines, and the supplemental recruitment solutions offered
to accelerate recruitment have been notoriously disjointed causing
inefficiencies for sites, sponsors, and CROs," said Elisa Cascade,
Advarra's Chief Product Officer. "Longboat consolidates all the
different streams of recruitment activities and status updates into
a simple, single real-time view. By removing friction from one of
research's biggest pain points, Longboat improves collaboration
between sites, sponsors and CROs which can accelerate trial
timelines."
Utilized in over 500 studies in the past four years, Longboat
streamlines clinical research by connecting all stakeholders –
sites, sponsors, and patients – to centralize and simplify trials
and deliver a better clinical research experience for all.
Advarra's new Longboat patient recruitment oversight capability
comes just months after launching single sign-on (SSO)
functionality, empowering sites to use their own site-sanctioned
credentials to access key systems including sponsor-provided
technology. Advarra introduced the SSO innovation to alleviate site
burden where nearly 70% of respondents report using six or more
logins per study.
Additional Information
- Learn more about Advarra's new patient recruitment
functionality in Longboat.
- Learn more about Advarra's site-specific clinical trial
technology:
www.advarra.com/solutions-for/clinical-trial-sites/
- Connect with Advarra on LinkedIn:
linkedin.com/company/advarra
About Advarra
Advarra breaks the silos that impede
clinical research, aligning patients, sites, sponsors, and CROs in
a connected ecosystem to accelerate trials. Advarra is number one
in research review services, site and sponsor technology, and
clinical trial experience software, and is trusted by the top 50
global biopharma sponsors, top 20 CROs, and 50,000 site
investigators worldwide. Advarra solutions enable collaboration,
transparency, and speed needed to optimize trial operations, ensure
patient safety and engagement, and reimagine clinical research
while improving compliance. For more information, visit
advarra.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/advarra-brings-together-clinical-trial-patient-recruitment-activities-to-centralize-visibility-and-accelerate-enrollment-302204778.html
SOURCE Advarra